Latest Jazz Pharmaceuticals plc Stories
First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S.
Approximately 79 percent of outstanding Gentium ordinary shares and American Depositary Shares tendered DUBLIN, Jan.
Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments DUBLIN, Jan.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, January 9, 2014 /PRNewswire/ -- Today, Analysts' Corner announced new research
DUBLIN, Jan. 6, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 32(nd) Annual J.P.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.